medical devices and innovations

Abbott engineered the HERO reader to be 60% lighter than its predecessor, making it practical for daily use and convenient enough for patients to carry during travel.

The proprietary CXLens system delivers patterned ultraviolet light to reshape the cornea while keeping the epithelium—the eye’s protective outer layer—completely intact.

The platform integrates visual inspection capabilities with advanced leak detection technology, processing up to 600 vials per minute while maintaining rigorous quality standards.

Unlike traditional rigid MRI coils that can feel cold and uncomfortable, the Snuggle coil wraps around patients like a soft blanket.

The initiatives align with the UAE’s national vision to foster innovation, accelerate digital transformation, and ensure citizens enjoy a high quality of life.

The system combines on-device artificial intelligence with multimodal sensing capabilities, point-of-care testing, and longitudinal patient modeling.

The acquisition encompasses MDCO’s complete portfolio of ophthalmic devices, including intraocular lenses (IOL), implantable contact lenses (Phakic Lens), and various refractive device platforms.

The 22 national standards, which include two pre-standards developed in 2024, specifically address the safe deployment of AI technologies in medical environments.

The acquisition adds two key products to BioStem’s portfolio: Neox and Clarix, both cryopreserved amniotic membrane allografts.